We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Inexpensive Biosensor Provides Rapid Diagnosis of Bacterial Infections

By LabMedica International staff writers
Posted on 11 Dec 2018
Print article
Image: Conceptual representation for the detection of bacteria concentration and proliferation. The electrical signal of the resonator is analyzed through a vector network analyzer (VNA) to gather resonant profile for bacteria in different concentrations and environmental pH, and for long-term screening of their growth (Photo courtesy of the University of British Columbia).
Image: Conceptual representation for the detection of bacteria concentration and proliferation. The electrical signal of the resonator is analyzed through a vector network analyzer (VNA) to gather resonant profile for bacteria in different concentrations and environmental pH, and for long-term screening of their growth (Photo courtesy of the University of British Columbia).
Bacterial infection is a common problem throughout hospitals around the worlds. Every hour of delay in antibiotic treatment increases the mortality rate of patients by 7.6% with sepsis and septic shocks.

The failure to diagnose early and critical stages of bacterial infections can be detrimental to a patient’s health and potentially fatal. The existing methods of diagnosing infections and performing antibiotic susceptibility testing (AST) suffer from a time-consuming and laborious process, typically taking up to 2 to 5 days to obtain accurate and reliable results.

Canadian bioengineers working with the University of British Columbia Okanagan (Kelowna, BC, Canada) have developed a microwave-microfluidic biosensor for rapid, contactless and non-invasive device for testing the concentration and growth of Escherichia coli (E. coli) in medium solutions of different pH to increase the efficacy of clinical microbiology practices. The team tested their device by tracking the amount of bacteria present in a variety of samples under various scenarios. The scenarios resembled those encountered in clinical microbiological laboratories.

The thin layer interface between the microfluidic channel and the microwave resonator significantly enhanced the detection sensitivity. The microfluidic chip, fabricated using standard soft lithography, was injected with bacterial samples and incorporated with a microwave microstrip ring resonator sensor with an operation frequency of 2.5 GHz and initial quality factor of 83 for detecting the concentration and growth of bacteria. The resonator had a coupling gap area on of 1.5 × 1.5 mm2 as of its sensitive region.

The presence of different concentrations of bacteria in different pH solutions was detected via screening the changes in resonant amplitude and frequency responses of the microwave system. The sensor device demonstrated near immediate response to changes in the concentration of bacteria and maximum sensitivity of 3.4 MHz compared to a logarithm value of bacteria concentration. The minimum prepared optical transparency of bacteria was tested at an OD600 value of 0.003. A highly linear response was demonstrated for detecting bacteria concentration at various pH values.

Mohammad Hossein Zarifi, PhD, an assistant professor and co-author of the study, said, “The device is able to rapidly detect bacteria and in addition, it screens the interaction of those bacteria with antibiotics. The combined results give health care practitioners more information than they currently have available, helping them move forward to determine accurate treatments. This biosensor is a significant step forward in improving the complex antibiotic susceptibility testing workflow and provides a rapid and automated detection of bacteria as well as screening the bacteria proliferation in response to antibiotics.” The study was published on October 25, 2018, in the journal Scientific Reports.

Related Links:
University of British Columbia Okanagan

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.